home / stock / lyra / lyra short
Short Information | Lyra Therapeutics Inc. (NASDAQ:LYRA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 5,787,722 |
Total Actual Volume | 28,734,295 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 289,386 |
Average Short Percentage | 24.92% |
Is there a LYRA Short Squeeze or Breakout about to happen?
See the LYRA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-26-2024 | $0.304 | $0.3076 | $0.309 | $0.2951 | 616,357 | 179,193 | 29.07% |
07-25-2024 | $0.2919 | $0.309 | $0.31 | $0.2831 | 793,172 | 319,936 | 40.34% |
07-24-2024 | $0.2909 | $0.2903 | $0.2989 | $0.285 | 776,281 | 126,101 | 16.24% |
07-23-2024 | $0.2856 | $0.2999 | $0.2999 | $0.2816 | 621,140 | 109,565 | 17.64% |
07-22-2024 | $0.28 | $0.289 | $0.289 | $0.2711 | 812,718 | 248,825 | 30.62% |
07-19-2024 | $0.29 | $0.28 | $0.2914 | $0.272 | 1,025,201 | 299,754 | 29.24% |
07-18-2024 | $0.3047 | $0.2889 | $0.3062 | $0.2881 | 861,566 | 220,302 | 25.57% |
07-17-2024 | $0.311 | $0.3063 | $0.3139 | $0.2953 | 984,846 | 342,233 | 34.75% |
07-16-2024 | $0.3049 | $0.31 | $0.3149 | $0.304 | 1,327,711 | 186,871 | 14.07% |
07-15-2024 | $0.2892 | $0.305 | $0.305 | $0.2892 | 1,252,682 | 267,788 | 21.38% |
07-12-2024 | $0.2919 | $0.291 | $0.3009 | $0.2835 | 1,212,562 | 334,546 | 27.59% |
07-11-2024 | $0.2896 | $0.292 | $0.2995 | $0.269 | 1,820,662 | 393,323 | 21.6% |
07-10-2024 | $0.2711 | $0.2927 | $0.294 | $0.2701 | 791,908 | 234,508 | 29.61% |
07-09-2024 | $0.2687 | $0.2712 | $0.2868 | $0.2647 | 1,307,224 | 470,544 | 36% |
07-08-2024 | $0.2719 | $0.2692 | $0.2795 | $0.2611 | 1,547,754 | 323,236 | 20.88% |
07-05-2024 | $0.28 | $0.272 | $0.2851 | $0.2664 | 822,814 | 159,282 | 19.36% |
07-03-2024 | $0.2799 | $0.28 | $0.2898 | $0.274 | 548,619 | 135,836 | 24.76% |
07-02-2024 | $0.299 | $0.28 | $0.299 | $0.28 | 1,055,235 | 287,054 | 27.2% |
07-01-2024 | $0.2728 | $0.2969 | $0.3075 | $0.2725 | 2,576,203 | 690,064 | 26.79% |
06-28-2024 | $0.2583 | $0.2767 | $0.2888 | $0.254 | 7,979,640 | 458,761 | 5.75% |
News, Short Squeeze, Breakout and More Instantly...
Lyra Therapeutics Inc. Company Name:
LYRA Stock Symbol:
NASDAQ Market:
Lyra Therapeutics Inc. Website:
WATERTOWN, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of patients with chronic rhinosinusitis (CRS), today announced that Maria Palasis, Ph.D., President and Chi...
WATERTOWN, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), today announced th...
-- ENLIGHTEN I Pivotal Phase 3 Trial of LYR-210 in Pre-Surgical Chronic Rhinosinusitis (CRS) on Track to Complete Enrollment in mid-2023 -- -- Data from BEACON Phase 2 Trial of LYR-220 in Post-Surgical CRS Anticipated Q4 2023 -- -- Advancing In-House Manufacturing Capabilities to ...